KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
14,910
-320 (-2.10%)
Last updated: Jun 27, 2025
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 170.14 billion as of June 27, 2025. Its market cap has decreased by -14.80% in one year.
Market Cap
170.14B
Enterprise Value
158.62B
Revenue
81.78B
Ranking
n/a
PE Ratio
56.94
Stock Price
14,910.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 170.14B, a decrease of -7.42%. That is a compound annual growth rate of -1.57%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 27, 2025 | 161.86B | -3.07% |
Dec 30, 2024 | 166.98B | -35.26% |
Dec 28, 2023 | 257.94B | 10.51% |
Dec 29, 2022 | 233.40B | -55.92% |
Dec 30, 2021 | 529.52B | 118.69% |
Dec 30, 2020 | 242.13B | 31.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 391.17T |
SK hynix | 170.17T |
Samsung Biologics | 71.46T |
LG Energy Solution | 68.33T |
Hyundai Motor Company | 45.04T |
Hanwha Aerospace | 41.99T |
Doosan Enerbility | 39.07T |
Kia Corporation | 38.55T |